Skip to content

Prevention of Atrial Tachycardia After a Right Atriotomy II

Prevention of Atrial Tachycardia After a Right Atriotomy II

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00709384
Enrollment
14
Registered
2008-07-03
Start date
2006-01-31
Completion date
2009-03-31
Last updated
2009-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Flutter

Brief summary

The investigators performed a prophylactic peroperative linear lesions connecting the tricuspid annulus with a right atriotomy and the atriotomy with the inferior caval vein to prevent atrial flutter on 15 consecutive adult patients undergoing surgery for congenital heart disease. Conduction time between electrodes placed on both sides of the lesions is measured on the second postoperative day. Coronary angiography and electrophysiology study using an electroanatomic mapping system to assess conduction across the line are performed three month after the operation.

Detailed description

We perform a prophylactic peroperative linear lesions connecting the tricuspid annulus with a right atriotomy (surgical dissection plus cryoablation) and the atriotomy with the inferior caval vein (cryoablation alone) to prevent atrial flutter on 15 consecutive adult patients undergoing surgery for congenital heart disease. Conduction times between electrodes placed on both sides of the lesions are measured on the second postoperative day. Coronary angiography and electrophysiology study using an electroanatomic mapping system to assess conduction across the line and to try to induce atrial flutter are performed three month after the operation.

Interventions

PROCEDUREProphylactic surgical lesion

A prophylactic peroperative linear lesions connecting the tricuspid annulus with a right atriotomy (surgical dissection plus cryoablation) and the atriotomy with the inferior caval vein (cryoablation alone).

Sponsors

Danish Heart Foundation
CollaboratorOTHER
Aarhus University Hospital Skejby
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Clinical indication for corrective operation for congenital heart disease with the use of a right lateral atriotomy, 2. Age \>18 years, 3. Ability to give an informed consent.

Exclusion criteria

1. Acute operation 2. Chronic atrial fibrillation 3. Indication for MAZE procedure

Design outcomes

Primary

MeasureTime frame
completeness of the lines of block3 month

Secondary

MeasureTime frame
safety3 month

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026